These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19725476)

  • 21. Population-based assessment of familial inheritance and neurologic comorbidities among patients with an isolated atrial septal defect.
    Steenblik MH; Mineau GP; Pimentel R; Michaels AD
    Congenit Heart Dis; 2009; 4(6):459-63. PubMed ID: 19925540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cases from the aerospace medicine residents' teaching file. Transient ischemic attack in an aviator with patent foramen ovale and Factor V Leiden.
    Radimer MC
    Aviat Space Environ Med; 2003 Dec; 74(12):1303-5. PubMed ID: 14692478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing for Thrombophilia in Young Cryptogenic Stroke Patients: Does the Presence of Patent Foramen Ovale Make a Difference?
    Jokubaitis M; Mineikytė R; Kryžauskaitė L; Gumbienė L; Kaplerienė L; Andruškevičius S; Ryliškienė K
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013523
    [No Abstract]   [Full Text] [Related]  

  • 24. High prevalence of inherited prothrombotic risk factors in 134 consecutive patients with von Willebrand disease.
    Franchini M; Veneri D; Poli G; Manzato F; Salvagno GL; Lippi G
    Am J Hematol; 2006 Jun; 81(6):465-7. PubMed ID: 16680739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral sinus thrombosis in a patient with active ulcerative colitis and double heterozygosity for Factor V Leiden and prothrombin gene mutations.
    Yakaryilmaz F; Guliter S; Degertekin B; Tuncer C; Unal S
    Neurol India; 2009; 57(2):188-90. PubMed ID: 19439852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke in Young Military Men With Heterozygous for MTHFR Gene Mutation or Factor V Leiden Gene Mutation Associated With Patent Foramen Ovale: Report of Two Cases and Therapeutic Strategy.
    Brisson RT; Arruda JFL; Silva LD; de Jesus DLJ; Zetola VF; Kauffmann Nogueira MAC
    Mil Med; 2023 Mar; 188(3-4):e885-e889. PubMed ID: 33993312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary antiphospholipid syndrome and factor V Leiden mutation in a young patient with non-bacterial thrombotic endocarditis and transient ischemic stroke.
    Letsas KP; Filippatos GS; Kounas SP; Pappas LK; Gavrielatos G; Kardaras F
    Thromb Haemost; 2005 Dec; 94(6):1331-2. PubMed ID: 16411415
    [No Abstract]   [Full Text] [Related]  

  • 29. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent thrombembolic risk in patients with multiple thrombophilic disorders.
    Agoşton-Coldea L; Rusu LD; Bobar C; Rusu ML; Mocan T; Procopciuc LM
    Rom J Intern Med; 2008; 46(3):261-6. PubMed ID: 19366087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay?
    Djordjevic V; Stankovic M; Brankovic-Sreckovic V; Rakicevic L; Radojkovic D
    J Child Neurol; 2009 Jul; 24(7):823-7. PubMed ID: 19372095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Migraine as predictive factor of the presence of atrial septum aneurysm in patients with stroke and patent foramen ovale].
    Martín Balbuena S; Fuentes B; Lara M; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E
    Neurologia; 2009 Apr; 24(3):160-4. PubMed ID: 19418291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    De Paulis S; Rossi E; Zamparelli R; Scapigliati A; Corrado M; De Stefano V
    Thromb Haemost; 2008 Feb; 99(2):441-2. PubMed ID: 18278197
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal ischemic stroke in postmenopausal women.
    Lemaitre RN; Psaty BM; Heckbert SR; Smith NL; Longstreth WT; Rosendaal FR
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):1051-2. PubMed ID: 12067921
    [No Abstract]   [Full Text] [Related]  

  • 37. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 38. Recurrent transient ischemic attacks in a 15-year-old boy with beta-thalassemia minor and thrombophilia. Contribution of perfusion SPECT to clinical diagnosis.
    Engelborghs S; Pickut BA; De Deyn PP
    Acta Neurol Belg; 2003 Jun; 103(2):99-102. PubMed ID: 12892004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.